Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00081_DB00108_nanopub.RA0GVSDZkbWGxh5vicEKRKT5hIInIh8SUSDLr0BV7-oTg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00081_DB00108 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00081_DB00108 label "DDI between Tositumomab and Natalizumab - The immunosuppressant, Tositumomab, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided. [drugbank_resource:DB00081_DB00108]" assertion.
- drugbank_resource:DB00081_DB00108 identifier "drugbank_resource:DB00081_DB00108" assertion.
- drugbank_resource:DB00081_DB00108 title "DDI between Tositumomab and Natalizumab - The immunosuppressant, Tositumomab, may increase the adverse effects of Natalizumab. Increased risk of Progressive Multifocal Leukoencephalopathy (PML) and other infections. Concurrent therapy should be avoided." assertion.
- drugbank:DB00108 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00081_DB00108 assertion.
- drugbank:DB00081 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00081_DB00108 assertion.